Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (6452)	2/11/1999 10:23:00 AM
From: Biomaven	Read Replies (1) \| Respond to of 9719

Rman, From today's HGSI release: At the current time, HGSI has filed patent applications on more than 2,800 novel human genes. The number of genes and proteins for which patent applications have published under the auspices of the Patent Cooperation Treaty is now over 1,100. The number of genes now covered by U.S. notices of patent allowance is 78, of which 56 are covered by issued patents. All of these patents and patent applications cover inventions based on full-length sequences of human genes with proposed medical applications. Seems like these guys have been busy as well, even though they now seem to be turning into a drug-development-type biotech. Lots of cash, fairly low burn all things considered. Any comments? Peter